Buscar en
Clínica e Investigación en Arteriosclerosis (English Edition)
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis (English Edition)
Journal Information
Issue
Vol. 33. Issue 2.
Pages 55-116 (March - April 2021)
Originals
Association of Inflammatory Markers with Multisite Artery Disease in Patients with Peripheral Arterial Disease
Zafer Yalım, Mustafa Aldemir, Sadık Volkan Emren
Clin Investig Arterioscler. 2021;33:55-61
Genetics and biochemistry of familial hypercholesterolemia in Southwest of the Iberian Peninsula
Jessica Roa Garrido, Pilar Carrasco Salas, Clara Toscano Pérez, Teresa Arrobas Velilla, Ignacio Vázquez Rico, José Francisco Díaz Fernández
Clin Investig Arterioscler. 2021;33:62-9
Editorial
Vitamin D, calcium and cardiovascular health: Foods or supplements? — What is the evidence in 2021?
Miguel Cainzos-Achirica
Clin Investig Arterioscler. 2021;33:70-2
Consensus document
Executive summary: Updates to the dietary treatment of prediabetes and type 2 diabetes mellitus
V. Pascual Fuster, A. Pérez Pérez, J. Carretero Gómez, A. Caixàs Pedragós, R. Gómez-Huelgas, P. Pérez-Martínez
Clin Investig Arterioscler. 2021;33:73-84
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines
Pedro Armario, Carlos Brotons, Roberto Elosua, Maria Alonso de Leciñana, Almudena Castro, Albert Clarà, Olga Cortés, Ángel Díaz Rodriguez, María Herranz, Soledad Justo, Carlos Lahoz, Juan Pedro-Botet, Antonio Pérez Pérez, Rafael Santamaria, Ricard Tresserras, Susana Aznar Lain, Miguel Ángel Royo-Bordonada
Clin Investig Arterioscler. 2021;33:85-107
Review
Uncovering the role of apolipoprotein C-III in insulin resistance
David Aguilar-Recarte, Xavier Palomer, Manuel Vázquez-Carrera
Clin Investig Arterioscler. 2021;33:108-15
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos